'Hunger hormone' may treat severe peripheral artery disease

(University of Otago) A new study by a team of researchers from New Zealand's University of Otago and Japan suggests that the appetite-regulating hormone ghrelin could be used clinically for the early treatment of critical limb ischemia, an advanced form of peripheral artery disease.